JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 28.58.
Share Price | ₹225.3 | Apr 22,2025 |
Market Cap | ₹1,495.7 Cr | |
Earnings-TTM | ₹52.3 Cr | TTM-Standalone Results |
Price/Earnings | 28.58x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,495.7 Cr] as on Apr 22,2025
(/) Earnings [ ₹52.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 28.58x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 28.58 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 24.59x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 28.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 5.81x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JAGSONPAL PHARMACEUTICALS | 52.33 | 28.58 | 1,495.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.50 | 419,224.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 75.98 | 157,046.0 |
CIPLA LTD | 5,000.43 | 24.68 | 123,416.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.99 | 109,834.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.06 | 98,036.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.82 | 106,262.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 18.68 | 85,781.5 |
LUPIN LTD | 2,892.10 | 32.31 | 93,454.3 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.71 | 69,005.0 |
ABBOTT INDIA LTD | 1,334.46 | 49.34 | 65,845.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.06x |
Max industry PE | 75.98x |
Median industry PE | 32.31x |
Average industry PE | 37.70x |
You may also like the below Video Courses